BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies | GenomeWeb

 

BioCommerce Week’s Index to the Diversified Molecular Biology Tools Companies

On a week when Merck withdrew its anti-inflammatory medicine Vioxx from the market, the BioCommerce Week Index of Diversified Molecular Biology Tools Companies recovered from last week’s 3-percent fall, registering a 2-percent gain for the weekly period ending Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.